KBC Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $373M | Sell |
2,679,656
-564,970
| -17% | -$79.1M | 0.94% | 13 |
|
|
2025
Q4 | $398M | Buy |
3,244,626
+283,659
| +10% | +$34.5M | 0.91% | 18 |
|
|
2025
Q3 | $329M | Buy |
2,960,967
+619,174
| +26% | +$70.4M | 0.79% | 18 |
|
|
2025
Q2 | $260M | Buy |
2,341,793
+496,708
| +27% | +$52.9M | 0.7% | 20 |
|
|
2025
Q1 | $207M | Sell |
1,845,085
-216,483
| -11% | -$22.3M | 0.64% | 25 |
|
|
2024
Q4 | $190M | Sell |
2,061,568
-220,951
| -10% | -$19.9M | 0.52% | 27 |
|
|
2024
Q3 | $191M | Sell |
2,282,519
-1,344,697
| -37% | -$103M | 0.58% | 26 |
|
|
2024
Q2 | $249M | Buy |
3,627,216
+468,039
| +15% | +$31.2M | 0.75% | 20 |
|
|
2024
Q1 | $231M | Buy |
3,159,177
+1,737,617
| +122% | +$134M | 0.74% | 25 |
|
|
2023
Q4 | $115M | Buy |
1,421,560
+184,805
| +15% | +$14.4M | 0.41% | 54 |
|
|
2023
Q3 | $92.7M | Sell |
1,236,755
-210,700
| -15% | -$16.2M | 0.38% | 57 |
|
|
2023
Q2 | $112M | Buy |
1,447,455
+515,435
| +55% | +$41.1M | 0.46% | 50 |
|
|
2023
Q1 | $77.3M | Buy |
932,020
+79,280
| +9% | +$6.57M | 0.33% | 68 |
|
|
2022
Q4 | $73.2M | Buy |
852,740
+56,923
| +7% | +$4.51M | 0.36% | 62 |
|
|
2022
Q3 | $49.1M | Buy |
795,817
+27,919
| +4% | +$1.76M | 0.26% | 93 |
|
|
2022
Q2 | $47.5M | Buy |
767,898
+77,533
| +11% | +$4.8M | 0.24% | 104 |
|
|
2022
Q1 | $41M | Sell |
690,365
-214,959
| -24% | -$13.7M | 0.16% | 153 |
|
|
2021
Q4 | $65.7M | Buy |
905,324
+76,445
| +9% | +$5.27M | 0.22% | 115 |
|
|
2021
Q3 | $57.9M | Sell |
828,879
-426,903
| -34% | -$30M | 0.21% | 121 |
|
|
2021
Q2 | $86.5M | Buy |
1,255,782
+228,782
| +22% | +$15.3M | 0.16% | 153 |
|
|
2021
Q1 | $66.4M | Buy |
1,027,000
+78,186
| +8% | +$5.04M | 0.13% | 187 |
|
|
2020
Q4 | $294M | Sell |
948,814
-168,046
| -15% | -$10.1M | 0.13% | 193 |
|
|
2020
Q3 | $70.6M | Buy |
1,116,860
+56,378
| +5% | +$3.91M | 0.21% | 113 |
|
|
2020
Q2 | $81.6M | Buy |
1,060,482
+452,576
| +74% | +$34.7M | 0.27% | 80 |
|
|
2020
Q1 | $45.4M | Sell |
607,906
-80,746
| -12% | -$5.58M | 0.38% | 57 |
|
|
2019
Q4 | $44.7M | Sell |
688,652
-130,094
| -16% | -$8.47M | 0.28% | 80 |
|
|
2019
Q3 | $51.9M | Buy |
818,746
+400,483
| +96% | +$26.2M | 0.38% | 51 |
|
|
2019
Q2 | $28.3M | Buy |
418,263
+55,323
| +15% | +$3.64M | 0.22% | 113 |
|
|
2019
Q1 | $23.6M | Sell |
362,940
-19,393
| -5% | -$1.29M | 0.19% | 127 |
|
|
2018
Q4 | $23.9M | Sell |
382,333
-53,410
| -12% | -$3.73M | 0.27% | 87 |
|
|
2018
Q3 | $33.6M | Buy |
435,743
+222,952
| +105% | +$16.8M | 0.25% | 101 |
|
|
2018
Q2 | $15.1M | Sell |
212,791
-17,951
| -8% | -$1.27M | 0.13% | 211 |
|
|
2018
Q1 | $17.4M | Sell |
230,742
-27,406
| -11% | -$2.18M | 0.16% | 166 |
|
|
2017
Q4 | $18.5M | Sell |
258,148
-486,685
| -65% | -$37M | 0.16% | 167 |
|
|
2017
Q3 | $60.3M | Buy |
744,833
+84,946
| +13% | +$6.5M | 0.55% | 35 |
|
|
2017
Q2 | $46.7M | Sell |
659,887
-632,994
| -49% | -$42.1M | 0.45% | 45 |
|
|
2017
Q1 | $87.8M | Buy |
1,292,881
+162,841
| +14% | +$11.5M | 0.79% | 15 |
|
|
2016
Q4 | $80.9M | Buy |
1,130,040
+128,513
| +13% | +$9.55M | 0.8% | 13 |
|
|
2016
Q3 | $79.2M | Buy |
1,001,527
+304,754
| +44% | +$24.8M | 0.94% | 12 |
|
|
2016
Q2 | $58.1M | Buy |
696,773
+217,111
| +45% | +$19.3M | 0.83% | 15 |
|
|
2016
Q1 | $44.1M | Sell |
479,662
-33,667
| -7% | -$3.04M | 0.73% | 19 |
|
|
2015
Q4 | $51.9M | Buy |
513,329
+21,151
| +4% | +$2.2M | 0.96% | 10 |
|
|
2015
Q3 | $48.3M | Sell |
492,178
-10,936
| -2% | -$1.21M | 0.97% | 10 |
|
|
2015
Q2 | $58.9M | Buy |
503,114
+211,641
| +73% | +$23.1M | 0.76% | 14 |
|
|
2015
Q1 | $28.6M | Sell |
291,473
-281,898
| -49% | -$28.6M | 0.37% | 70 |
|
|
2014
Q4 | $54M | Buy |
573,371
+369,189
| +181% | +$38.2M | 0.64% | 23 |
|
|
2014
Q3 | $21.7M | Sell |
204,182
-794,879
| -80% | -$77.8M | 0.76% | 11 |
|
|
2014
Q2 | $82.8M | Sell |
999,061
-70,244
| -7% | -$5.47M | 0.95% | 14 |
|
|
2014
Q1 | $75.8M | Sell |
1,069,305
-48,466
| -4% | -$3.8M | 1.2% | 8 |
|
|
2013
Q4 | $83.9M | Buy |
1,117,771
+47,956
| +4% | +$3.34M | 1.27% | 9 |
|
|
2013
Q3 | $67.3M | Buy |
1,069,815
+230,253
| +27% | +$13.8M | 1.08% | 9 |
|
|
2013
Q2 | $43M | Buy |
+839,562
| New | +$43.8M | 0.8% | 16 |
|
Other funds holding GILD
VCM
VPM
KBC Group's GILD Position: Q1 2026 in Review
KBC Group reduced its Gilead Sciences (GILD) stake by 17% in Q1 2026, selling an estimated $79.1M and leaving 2,679,656 shares worth $373M. The position accounts for 0.94% of the portfolio, ranked #13.
KBC Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $398M in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- KBC Group held 2,679,656 shares of Gilead Sciences worth $373M as of Q1 2026.
- KBC Group sold 564,970 Gilead Sciences shares in Q1 2026, an estimated $79.1M.
- Gilead Sciences made up 0.94% of KBC Group's portfolio in Q1 2026, its #13 holding.
- KBC Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Gilead Sciences position peaked at $398M in Q4 2025.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.